Douglas W. Thomson
GlaxoSmithKline (Germany)(DE)
Publications by Year
Research Areas
Radical Photochemical Reactions, Catalytic C–H Functionalization Methods, Catalytic Cross-Coupling Reactions, Monoclonal and Polyclonal Antibodies Research, Click Chemistry and Applications
Most-Cited Works
- → Identifying drug targets in tissues and whole blood with thermal-shift profiling(2020)188 cited
- → Highly Efficient Reduction of Unactivated Aryl and Alkyl Iodides by a Ground‐State Neutral Organic Electron Donor(2005)161 cited
- → The Generation of Aryl Anions by Double Electron Transfer to Aryl Iodides from a Neutral Ground‐State Organic Super‐Electron Donor(2007)136 cited
- → Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor(2019)87 cited
- → A Modular Probe Strategy for Drug Localization, Target Identification and Target Occupancy Measurement on Single Cell Level(2016)85 cited
- → Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization(2010)70 cited
- → Two-Step Synthesis of Aza- and Diazaindoles from Chloroamino-N-heterocycles Using Ethoxyvinylborolane(2009)70 cited
- → Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives(2016)59 cited
- → Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells(2019)58 cited
- → Imidazole-derived carbenes and their elusive tetraazafulvalene dimers(2012)50 cited